Global Botanical Drug Market Insights, Forecast to 2029

Global Botanical Drug Market Insights, Forecast to 2029

Market Analysis and Insights: Global Botanical Drug Market

The global Botanical Drug market is projected to grow from US$ 38164 million in 2023 to US$ 50499.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.78% during the forecast period.

The North America market for Botanical Drug is estimated to increase from $ 1682.4 million in 2023 to reach $ 2342 million by 2029, at a CAGR of 5.67% during the forecast period of 2024 through 2029.

The China market for Botanical Drug is estimated to increase from $ 22212 million in 2023 to reach $ 28796 million by 2029, at a CAGR of 4.42% during the forecast period of 2024 through 2029.

The Europe market for Botanical Drug is estimated to increase from $ 6650 million in 2023 to reach $ 9229 million by 2029, at a CAGR of 5.61% during the forecast period of 2024 through 2029.

The global key companies of Botanical Drug include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Guangzhou Baiyunshan Pharmaceutical, Tasly Holding Group, Jumpcan Pharmaceutical, Yunnan Baiyao, etc. In 2022, the global top five players had a share approximately 19.65 % in terms of revenue.

Report Includes

This report presents an overview of global market for Botanical Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Botanical Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Botanical Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Botanical Drugrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Botanical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Botanical Drug revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, and Tasly Holding Group, etc.

By Company

Buchang Pharmaceuticals

China TCM

Tsumura

Schwabe

Tong Ren Tang

Jumpcan Pharmaceutical

Guangzhou Baiyunshan

Yunnan Baiyao

Tasly Holding Group

Bionorica Se

Huarun 999

Taiji

Weleda

Kwangdong

GW Pharmaceuticals

Segment by Type

Prescription Drug

OTC

Segment by Application

Cardiovascular

Tumor

Respiratory System

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Europe

Germany

France

U.K.

Italy

Russia

Rest of Europe

Latin America

Mexico

Brazil

Middle East & Africa

Middle East

Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Botanical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Botanical Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (North America) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical Drugrevenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions